Exane Derivatives’s Centerra Gold CGAU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$1.26K Buy
+186
New +$1.57K ﹤0.01% 482
2022
Q1
Sell
-186
Closed -$1.43K 1025
2021
Q4
$1.43K Hold
186
﹤0.01% 682
2021
Q3
$1.26K Hold
186
﹤0.01% 834
2021
Q2
$1.37K Buy
+186
New +$1.55K ﹤0.01% 847

Other funds holding CGAU

Exane Derivatives's CGAU Position: Q2 2022 in Review

Exane Derivatives opened a new position in Centerra Gold (CGAU) in Q2 2022: 186 shares worth $1.26K. The stake represents ﹤0.01% of the portfolio and ranks #482 among its holdings. This is a return to the name: Exane Derivatives previously reported a position in CGAU as recently as Q4 2021.

Exane Derivatives first reported a position in CGAU in Q2 2021 and has held it in 4 quarters since. The position peaked at $1.43K in Q4 2021. 97 funds tracked by Wall St. Rank hold CGAU as of Q2 2022.

  • Exane Derivatives held 186 shares of Centerra Gold worth $1.26K as of Q2 2022.
  • Centerra Gold was a new Exane Derivatives position in Q2 2022.
  • Centerra Gold made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #482 holding.
  • Exane Derivatives first reported a position in Centerra Gold in Q2 2021 and has held it in 4 quarters since.
  • Exane Derivatives's Centerra Gold position peaked at $1.43K in Q4 2021.
  • 97 funds tracked by Wall St. Rank held Centerra Gold as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.